Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasma
Crossref DOI link: https://doi.org/10.1007/s00280-016-3033-7
Published Online: 2016-04-21
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Jia
Kluger, Harriet
Devine, Lesley
Lee, James J.
Kelly, William Kevin
Rink, Linda
Saif, Muhammad Wasif
Text and Data Mining valid from 2016-04-21